BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22913147)

  • 1. From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression.
    Wang Y; Li J; Chen J; Liu L; Peng Z; Ding J; Ding K
    Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):995-1000. PubMed ID: 22913147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma.
    Cheng P; Cheng Y; Su MX; Li D; Zhao GZ; Gao H; Li Y; Zhu JY; Li H; Zhang T
    Asian Pac J Cancer Prev; 2012; 13(8):3741-5. PubMed ID: 23098464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXP1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infection.
    Li F; Liu T; Xiao CY; Yu JX; Lu LG; Xu MY
    Biomed Pharmacother; 2015 May; 72():103-8. PubMed ID: 26054682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma.
    Tsunedomi R; Iizuka N; Hamamoto Y; Uchimura S; Miyamoto T; Tamesa T; Okada T; Takemoto N; Takashima M; Sakamoto K; Hamada K; Yamada-Okabe H; Oka M
    Int J Oncol; 2005 Sep; 27(3):661-7. PubMed ID: 16077914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R
    Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
    Cheng Y; Ping J; Chen J
    Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.
    Smith MW; Yue ZN; Geiss GK; Sadovnikova NY; Carter VS; Boix L; Lazaro CA; Rosenberg GB; Bumgarner RE; Fausto N; Bruix J; Katze MG
    Cancer Res; 2003 Feb; 63(4):859-64. PubMed ID: 12591738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients.
    Shao RX; Hoshida Y; Otsuka M; Kato N; Tateishi R; Teratani T; Shiina S; Taniguchi H; Moriyama M; Kawabe T; Omata M
    World J Gastroenterol; 2005 Apr; 11(13):1995-9. PubMed ID: 15800993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
    Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K
    Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Bornstein K; Fisher RA
    Transplantation; 2009 Jan; 87(1):143-52. PubMed ID: 19136905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysis.
    Wang F; Chang Y; Li J; Wang H; Zhou R; Qi J; Liu J; Zhao Q
    Dig Liver Dis; 2017 Jan; 49(1):70-76. PubMed ID: 27876500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.
    Hass HG; Jobst J; Vogel U; Scheurlen M; Nehls O
    Oncol Res Treat; 2014; 37(12):732-8. PubMed ID: 25531719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.